Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
Prospective Post Market Clinical Follow-Up Study of the Continuum Metal on Polyethylene Acetabular System
Sponsor: Zimmer Biomet
Listed as NCT01307384, this observational or N/A phase trial focuses on Avascular Necrosis and Inflammatory Arthritis and remains ongoing. Sponsored by Zimmer Biomet, it has been updated 18 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
18 versions recorded-
Jul 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Nov 2022 — Sep 2023 [monthly]
Active Not Recruiting
▶ Show 13 earlier versions
-
Oct 2021 — Nov 2022 [monthly]
Active Not Recruiting
-
Jun 2021 — Oct 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Active Not Recruiting
-
Sep 2019 — Feb 2020 [monthly]
Active Not Recruiting
-
Mar 2019 — Sep 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — Feb 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .